InsidersTradesSigma
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
22
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Crocker Gary l, Executive. Insider active across 1 company, notably Merrimack Pharmaceuticals INC. Aggregated, 22 filings have been published. Split: 22 buys · 0 sell. Total volume traded: €336k. History available since 11 January 2022. The latest transaction was filed on 10 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Crocker Gary l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
2,000 shares@ US$12.51965.0% of flowCommon StockSEC:0000950170-23-042384:0
Canonical exit: 8 Nov 2023 (T+90)
4,452 shares@ US$5.14784.9% of flowCommon StockSEC:0000899243-22-022153:0
Canonical exit: 7 Sept 2022 (T+90)
300 shares@ US$5.050.3% of flowCommon StockSEC:0000899243-22-021612:0
Canonical exit: 5 Sept 2022 (T+90)
2,323 shares@ US$5.08692.5% of flowCommon StockSEC:0000899243-22-019682:0
Canonical exit: 22 Aug 2022 (T+90)
512 shares@ US$5.04280.6% of flowCommon StockSEC:0000899243-22-019200:0
Canonical exit: 17 Aug 2022 (T+90)
225 shares@ US$5.09560.2% of flowCommon StockSEC:0000899243-22-018778:0
Canonical exit: 15 Aug 2022 (T+90)
2,471 shares@ US$5.04092.7% of flowCommon StockSEC:0000899243-22-018126:0
Canonical exit: 10 Aug 2022 (T+90)
5,000 shares@ US$6.00026.3% of flowCommon StockSEC:0000899243-22-015556:0
Canonical exit: 20 Jul 2022 (T+90)
161 shares@ US$6.200.2% of flowCommon StockSEC:0000899243-22-013091:0
Canonical exit: 28 Jun 2022 (T+90)
5,000 shares@ US$6.16436.4% of flowCommon StockSEC:0000899243-22-012692:0
Canonical exit: 26 Jun 2022 (T+90)
400 shares@ US$6.11380.5% of flowCommon StockSEC:0000899243-22-012077:0
Canonical exit: 20 Jun 2022 (T+90)
4,649 shares@ US$6.14236.0% of flowCommon StockSEC:0000899243-22-011381:0
Canonical exit: 13 Jun 2022 (T+90)
5,000 shares@ US$6.08136.3% of flowCommon StockSEC:0000899243-22-011037:0
Canonical exit: 9 Jun 2022 (T+90)
3,351 shares@ US$5.95934.0% of flowCommon StockSEC:0000899243-22-007378:0
Canonical exit: 19 May 2022 (T+90)
7,945 shares@ US$6.19659.9% of flowCommon StockSEC:0000899243-22-007005:0
Canonical exit: 17 May 2022 (T+90)
1,800 shares@ US$5.95762.2% of flowCommon StockSEC:0000899243-22-006627:0
Canonical exit: 15 May 2022 (T+90)
673 shares@ US$4.600.6% of flowCommon StockSEC:0000899243-22-003632:0
Canonical exit: 27 Apr 2022 (T+90)
3,100 shares@ US$4.55522.9% of flowCommon StockSEC:0000899243-22-003422:0
Canonical exit: 26 Apr 2022 (T+90)
2,000 shares@ US$4.65481.9% of flowCommon StockSEC:0000899243-22-003136:0
Canonical exit: 21 Apr 2022 (T+90)
5,000 shares@ US$4.53794.6% of flowCommon StockSEC:0000899243-22-002634:0
Canonical exit: 18 Apr 2022 (T+90)
5,000 shares@ US$4.42414.4% of flowCommon StockSEC:0000899243-22-002118:0
Canonical exit: 13 Apr 2022 (T+90)
5,000 shares@ US$4.02814.1% of flowCommon StockSEC:0000899243-22-001895:0
Canonical exit: 11 Apr 2022 (T+90)
22 of 22 declarations
About Crocker Gary l
Gary L. Crocker is an insider at Merrimack Pharmaceuticals Inc.
